Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-17 Purchase |
2023-03-17 5:03 pm |
Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO |
6,300 | $7.8623 | $49,532 | 12,800 (Direct) |
View |
| 2023-03-09 Purchase |
2023-03-09 5:56 pm |
Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO |
6,500 | $7.735 | $50,278 | 6,500 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-03 8:37 pm |
Aclaris Therapeutics Inc. | ACRS | Walker Neal Director |
59,240 | $12.5 | $740,658 | 1,400,006 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-03 8:12 pm |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
30,837 | $12.51 | $385,639 | 293,192 (Indirect Direct) |
View |
| 2023-03-02 Sale |
2023-03-03 8:09 pm |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
1,894 | $12.45 | $23,579 | 16,081 (Direct) |
View |
| 2023-02-15 Sale |
2023-02-17 4:34 pm |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
5,000 | $13.06 | $65,310 | 91,579 (Indirect Direct) |
View |
| 2023-02-08 Sale |
2023-02-10 4:55 pm |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
4,267 | $13.89 | $59,272 | 6,983 (Direct) |
View |
| 2023-02-01 Sale |
2023-02-03 5:09 pm |
Aclaris Therapeutics Inc. | ACRS | Walker Neal Director |
30,000 | $16.66 | $499,923 | 1,175,763 (Direct) |
View |
| 2023-01-03 Sale |
2023-01-04 6:20 pm |
Aclaris Therapeutics Inc. | ACRS | Walker Neal Director |
40,000 | $15.11 | $604,556 | 1,205,763 (Direct) |
View |
| 2022-12-15 Sale |
2022-12-16 4:57 pm |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
5,000 | $15.88 | $79,412 | 96,579 (Indirect Direct) |
View |
| 2022-11-10 Sale |
2022-11-14 4:51 pm |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
53,926 | $17.05 | $919,589 | 434,455 (Indirect Direct) |
View |
| 2022-10-24 Sale |
2022-10-26 7:09 pm |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
41,174 | $17.01 | $700,355 | 488,381 (Indirect Direct) |
View |
| 2022-10-17 Sale |
2022-10-19 4:49 pm |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
52,037 | $16.57 | $862,109 | 529,555 (Indirect Direct) |
View |
| 2022-10-17 Sale |
2022-10-19 4:45 pm |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
5,000 | $15.98 | $79,908 | 101,579 (Indirect Direct) |
View |
| 2022-10-07 Sale |
2022-10-11 4:35 pm |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
7,324 | $16.16 | $118,349 | 581,592 (Indirect Direct) |
View |
| 2022-10-04 Sale |
2022-10-06 5:58 pm |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
45,539 | $16.45 | $749,002 | 588,916 (Indirect Direct) |
View |
| 2022-06-17 Sale |
2022-06-21 4:57 pm |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
19,565 | $15.14 | $296,269 | 634,455 (Indirect Direct) |
View |
| 2022-04-21 Sale |
2022-04-25 5:13 pm |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO |
70,000 | $15.15 | $1,060,701 | 1,245,763 (Direct) |
View |
| 2022-04-18 Sale |
2022-04-20 5:06 pm |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
30,000 | $16.28 | $488,298 | 106,579 (Indirect Direct) |
View |
| 2022-03-11 Sale |
2022-03-14 4:58 pm |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO |
56,303 | $15.91 | $896,045 | 1,315,763 (Direct) |
View |
| 2022-03-10 Sale |
2022-03-14 4:56 pm |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
12,823 | $15.55 | $199,335 | 201,883 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-01 Exercise |
2023-03-03 8:37 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal Director |
156,679 | $0 | 1,400,006 (Direct) |
View |
| 2023-03-01 Exercise |
2023-03-03 8:12 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
87,175 | $0 | 293,192 (Direct) |
View |
| 2023-03-01 Exercise |
2023-03-03 8:09 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
6,450 | $0 | 16,081 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 5:07 pm |
N/A 2033-01-31 |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 5:04 pm |
N/A 2033-01-31 |
Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO |
486,000 | $0 | 486,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 5:01 pm |
N/A 2033-01-31 |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
135,000 | $0 | 180,000 (Direct) |
View |
| 2023-02-01 Exercise |
2023-02-03 5:01 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
11,250 | $0 | 180,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:58 pm |
N/A 2033-01-31 |
Aclaris Therapeutics Inc. | ACRS | Cawkwell Gail Chief Medical Officer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:55 pm |
N/A 2033-01-31 |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2022-11-08 Gift |
2023-01-20 5:08 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director |
4,000 | $0 | 9,856 (Direct) |
View |
Ownership |
2023-01-06 4:31 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
0 | $0 | 82,175 (Direct) |
View |
| 2022-08-01 Option Award |
2022-08-02 5:10 pm |
N/A 2032-07-31 |
Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and COO |
280,100 | $0 | 280,100 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-05 5:01 pm |
N/A 2032-06-30 |
Aclaris Therapeutics Inc. | ACRS | Cawkwell Gail Chief Medical Officer |
270,000 | $0 | 270,000 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 5:36 pm |
N/A 2032-06-01 |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
20,257 | $0 | 674,277 (Direct) |
View |
| 2022-06-03 Exercise |
2022-06-06 5:36 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
3,356 | $0 | 674,277 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 5:33 pm |
N/A 2032-06-01 |
Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director |
20,257 | $0 | 39,822 (Direct) |
View |
| 2022-06-03 Exercise |
2022-06-06 5:33 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director |
3,356 | $0 | 39,822 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 5:30 pm |
N/A 2032-06-01 |
Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director |
20,257 | $0 | 34,113 (Direct) |
View |
| 2022-05-16 Gift |
2022-06-06 5:30 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director |
709 | $0 | 34,113 (Direct) |
View |
| 2022-06-03 Exercise |
2022-06-06 5:30 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director |
3,356 | $0 | 34,113 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 5:27 pm |
N/A 2032-06-01 |
Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director |
20,257 | $0 | 47,504 (Direct) |
View |
| 2022-06-03 Exercise |
2022-06-06 5:27 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director |
3,356 | $0 | 47,504 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 5:24 pm |
N/A 2032-06-01 |
Aclaris Therapeutics Inc. | ACRS | MILANO VINCENT Director |
20,257 | $0 | 23,613 (Direct) |
View |
| 2022-06-03 Exercise |
2022-06-06 5:24 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | MILANO VINCENT Director |
3,356 | $0 | 23,613 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 5:21 pm |
N/A 2032-06-01 |
Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director |
20,257 | $0 | 54,454 (Direct) |
View |
| 2022-06-03 Exercise |
2022-06-06 5:21 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director |
3,356 | $0 | 54,454 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 5:18 pm |
N/A 2032-06-01 |
Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director |
20,257 | $0 | 39,822 (Direct) |
View |
| 2022-06-03 Exercise |
2022-06-06 5:18 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director |
3,356 | $0 | 39,822 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 5:15 pm |
N/A 2032-06-01 |
Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director |
20,257 | $0 | 28,051 (Direct) |
View |
| 2022-06-03 Exercise |
2022-06-06 5:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director |
3,356 | $0 | 28,051 (Direct) |
View |